This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grégoire, M.-C.
Right arrow Articles by Glorieux, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grégoire, M.-C.
Right arrow Articles by Glorieux, J.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 101 No. 5 May 1998, pp. 856-860

Health and Developmental Outcomes at 18 Months in Very Preterm Infants With Bronchopulmonary Dysplasia

Received Jan 8, 1997; accepted Aug 25, 1997.

Marie-Claude Grégoire*, Francine Lefebvre*, Dagger , and Jacqueline Glorieux*, Dagger

From the * Université de Montréal and the Dagger  Department of Pediatrics, Hôpital Ste-Justine and Université de Montréal, Montréal, Canada.

Objective.  To determine whether very preterm infants who are oxygen-dependent at 28 days of life but not at 36 weeks' gestational age are at high risk of morbidities at 18 months.

Population.  A total of 217 infants born in a tertiary care center at 24 to 28 weeks' gestation in 1987 to 1992, classified into three groups: neonatal comparison group, O2 <28 days of life (n = 76); bronchopulmonary dysplasia (BPD)-1, O2 >= 28 days but not at 36 weeks' gestational age (n = 48); and BPD-2, O2 >= 36 weeks (n = 93).

Outcome Measures.  Growth, persistent respiratory problems (asthma, tracheostomy, home oxygen therapy), surgery, hospitalizations, and neurodevelopmental impairments.

Results.  Among the three groups, no differences were found in weight, height, head circumference, or total number of days of rehospitalizations for any causes, or in rate of rehospitalizations to the intensive care unit, persistent respiratory problems, cerebral palsy, or sensory impairment. Children with BPD-2 needed more hernia repairs compared with the other two groups (comparison group: 12% vs BPD-1: 10% vs BPD-2: 30%), had more days of readmissions for respiratory problems (comparison group: 2.0 vs BPD-1: 2.0 vs BPD-2 6.3 [BPD-1 vs BPD-2]), had a lower mean developmental quotient (comparison group: 97.4 ± 15.0 vs BPD-1: 97.9 ± 11.6 vs BPD-2: 90.7 ± 19.3). Intraparenchymal cerebral lesions, high family adversity, and prolonged ventilation were the most important factors influencing the developmental outcome.

Conclusion.  Children with BPD-1 are similar in all respect at 18 months to children in the comparison group. Children with BPD-2 are similar to the other groups at 18 months in growth, general health, and neurologic outcome but differ in having a higher number of days of rehospitalizations for respiratory causes, more hernia repairs, and more developmental delays.

Key words: premature infants, bronchopulmonary dysplasia, neurodevelopmental outcomes, very low birth weight infants, chronic lung disease of prematurity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
J. E. Prasse and G. E. Kikano
An Overview of Pediatric Dysphagia
Clinical Pediatrics, April 1, 2009; 48(3): 247 - 251.
[Abstract] [PDF]

Home page
 PediatricsHome page
J. Zeitlin, E. S. Draper, L. Kollee, D. Milligan, K. Boerch, R. Agostino, L. Gortner, P. Van Reempts, J.-L. Chabernaud, J. Gadzinowski, et al.
Differences in Rates and Short-term Outcome of Live Births Before 32 Weeks of Gestation in Europe in 2003: Results From the MOSAIC Cohort
Pediatrics, April 1, 2008; 121(4): e936 - e944.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. R. Wilkinson, D. M. Brosi, and Z. D. Jiang
Functional Impairment of the Brainstem in Infants With Bronchopulmonary Dysplasia
Pediatrics, August 1, 2007; 120(2): 362 - 371.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. Lainwala, R. Perritt, K. Poole, B. Vohr, and for the National Institute of Child Health and Hum
Neurodevelopmental and Growth Outcomes of Extremely Low Birth Weight Infants Who Are Transferred From Neonatal Intensive Care Units to Level I or II Nurseries
Pediatrics, May 1, 2007; 119(5): e1079 - e1087.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
D. K. Thompson, S. K. Warfield, J. B. Carlin, M. Pavlovic, H. X. Wang, M. Bear, M. J. Kean, L. W. Doyle, G. F. Egan, and T. E. Inder
Perinatal risk factors altering regional brain structure in the preterm infant
Brain, March 1, 2007; 130(3): 667 - 677.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. A. Ehrenkranz, M. C. Walsh, B. R. Vohr, A. H. Jobe, L. L. Wright, A. A. Fanaroff, L. A. Wrage, K. Poole, and for the National Institutes of Child Health and Hu
Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia
Pediatrics, December 1, 2005; 116(6): 1353 - 1360.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
S. N. J. Kazzi, U. O. Kim, M. W. Quasney, and I. Buhimschi
Association Study of Gene Polymorphism and Bronchopulmonary Dysplasia: In Reply
Pediatrics, January 1, 2005; 115(1): 199 - 199.
[Full Text] [PDF]

Home page
 NEJMHome page
L. M. Askie, D. J. Henderson-Smart, L. Irwig, and J. M. Simpson
Oxygen-Saturation Targets and Outcomes in Extremely Preterm Infants
N. Engl. J. Med., September 4, 2003; 349(10): 959 - 967.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
Y. E. Vaucher
Bronchopulmonary Dysplasia: An Enduring Challenge
Pediatr. Rev., October 1, 2002; 23(10): 349 - 358.
[Full Text] [PDF]

Home page
 PediatricsHome page
H. L. Halliday, C. C. Patterson, C. W. N. L. Halahakoon, and on Behalf of the European Multicenter Steroid Stud
A Multicenter, Randomized Open Study of Early Corticosteroid Treatment (OSECT) in Preterm Infants With Respiratory Illness: Comparison of Early and Late Treatment and of Dexamethasone and Inhaled Budesonide
Pediatrics, February 1, 2001; 107(2): 232 - 240.
[Abstract] [Full Text]

Home page
 PediatricsHome page
B. R. Vohr, L. L. Wright, A. M. Dusick, L. Mele, J. Verter, J. J. Steichen, N. P. Simon, D. C. Wilson, S. Broyles, C. R. Bauer, et al.
Neurodevelopmental and Functional Outcomes of Extremely Low Birth Weight Infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994
Pediatrics, June 1, 2000; 105(6): 1216 - 1226.
[Abstract] [Full Text]

Home page
 PediatricsHome page
K. L. Watterberg, J. S. Gerdes, K. L. Gifford, and H.-M. Lin
Prophylaxis Against Early Adrenal Insufficiency to Prevent Chronic Lung Disease in Premature Infants
Pediatrics, December 1, 1999; 104(6): 1258 - 1263.
[Abstract] [Full Text]

Home page
 NEJMHome page
Y. A. Bental, A. Rotschild, P. A. Cooper, B. J. Boucher, and J. Tyson
Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
N. Engl. J. Med., November 25, 1999; 341(22): 1697 - 1698.
[Full Text]

Home page
 PediatricsHome page
T. Kasemsri;, R. A. Ballard, B. A. Banks;, F. Lefebvre, M.-C. Grégoire, and J. Glorieux
Definition of Bronchopulmonary Dysplasia
Pediatrics, February 1, 1999; 103(2): 533 - 534.
[Full Text]